[1]
Hiwrale, R.S., Tayade, G.S., Pennamareddy, R., Salunkhe, K., Shendge, R.S. and Kulkarni, A.D. 2022. Pre-submission facility correspondence for generic dosage form with an expedited-approval in 8 months. International journal of health sciences. 6, S3 (May 2022), 8478–8484. DOI:https://doi.org/10.53730/ijhs.v6nS3.8005.